Royalty Pharma plc (RPRX)

Sector:Health Care
Super Investor Stats:
Ownership count:3
Ownership rank:221
% of all portfolios:0.065%
Hold Price * :$28.09
History Portfolio Manager Activity ▼ Share change % change to portfolio
Q4  2023
≡ Torray Funds Add 22.56% 93,107 0.42
≡ Viking Global Investors Add 6.58% 623,216 0.06
≡ Samantha McLemore - Patient Capital Management Buy 1,254,780 1.87
Q2  2023
≡ Torray Funds Add 201.68% 276,643 1.47
Q1  2023
≡ Viking Global Investors Add 11.95% 1,195,738 0.20
Q3  2022
≡ Torray Funds Add 0.01% 12 0.00
Q2  2022
≡ Viking Global Investors Add 14.92% 1,606,222 0.31
≡ Torray Funds Add 5.26% 6,942 0.06
Q1  2022
≡ Viking Global Investors Add 4.35% 449,094 0.07
Q4  2021
≡ Viking Global Investors Add 149.13% 6,174,870 0.71
≡ Torray Funds Buy 137,941 0.81
Q3  2021
≡ Viking Global Investors Add 27.85% 901,854 0.09
≡ Warren Buffett - Berkshire Hathaway Buy 13,145,902 0.16
Q2  2021
≡ Viking Global Investors Add 57.08% 1,176,901 0.15
Q1  2021
≡ Lee Ainslie - Maverick Capital Buy 7,342 0.00
Q4  2020
≡ Viking Global Investors Add 17.40% 338,936 0.05
Q2  2020
≡ Viking Global Investors Buy 2,514,985 0.53

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.